Literature DB >> 18053067

The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae.

Hasan Yesilkaya, Sonia Manco, Aras Kadioglu, Vanessa S Terra, Peter W Andrew.   

Abstract

Streptococcus pneumoniae colonizes the mucin-rich environment of the nasopharynx. As colonization may be the first stage of infection, investigation was carried out as to whether the pneumococcus could utilize mucin as a source of nutrient and whether its virulence gene expression is influenced by this glycoprotein. It was found that when grown in Sicard's defined medium supplemented with 1% w/v mucin, the organism grew at a rate similar to that in rich medium. The presence of sialate O-acetylesterase activity, an enzyme implicated in glycoprotein degradation, in pneumococcal cell extracts was also reported. The authors hypothesized that neuraminidase A, which is linked to pneumococcal virulence, plays an important role in mucin utilization. Growth in mucin resulted in an increase in nanA transcription and a DeltananA-deficient strain of pneumococcus could not grow when mucin was used as the sole carbon source.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053067     DOI: 10.1111/j.1574-6968.2007.01003.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  41 in total

1.  Sialic acid-mediated gene expression in Streptococcus pneumoniae and role of NanR as a transcriptional activator of the nan gene cluster.

Authors:  Muhammad Afzal; Sulman Shafeeq; Hifza Ahmed; Oscar P Kuipers
Journal:  Appl Environ Microbiol       Date:  2015-02-27       Impact factor: 4.792

2.  Sialic acid transport contributes to pneumococcal colonization.

Authors:  Carolyn Marion; Amanda M Burnaugh; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

3.  LacR is a repressor of lacABCD and LacT is an activator of lacTFEG, constituting the lac gene cluster in Streptococcus pneumoniae.

Authors:  Muhammad Afzal; Sulman Shafeeq; Oscar P Kuipers
Journal:  Appl Environ Microbiol       Date:  2014-06-20       Impact factor: 4.792

4.  The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation.

Authors:  Dane Parker; Grace Soong; Paul Planet; Jonathan Brower; Adam J Ratner; Alice Prince
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Absence of capsule reveals glycan-mediated binding and recognition of salivary mucin MUC7 by Streptococcus pneumoniae.

Authors:  S Thamadilok; H Roche-Håkansson; A P Håkansson; S Ruhl
Journal:  Mol Oral Microbiol       Date:  2015-08-17       Impact factor: 3.563

Review 6.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

7.  Thiol peroxidase is an important component of Streptococcus pneumoniae in oxygenated environments.

Authors:  Barak Hajaj; Hasan Yesilkaya; Rachel Benisty; Maayan David; Peter W Andrew; Nurith Porat
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

8.  Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae.

Authors:  Vanessa S Terra; Karen A Homer; Susmitha G Rao; Peter W Andrew; Hasan Yesilkaya
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

9.  Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization.

Authors:  Ernesto J Muñoz-Elías; Joan Marcano; Andrew Camilli
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

10.  Pyruvate formate lyase is required for pneumococcal fermentative metabolism and virulence.

Authors:  Hasan Yesilkaya; Francesca Spissu; Sandra M Carvalho; Vanessa S Terra; Karen A Homer; Rachel Benisty; Nurith Porat; Ana R Neves; Peter W Andrew
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.